- Age, Sex, and Body Mass Index Should Be Considered When Assessing Spleen Length in Patients with Compensated Advanced Chronic Liver Disease
-
Lee HA, Kim SU, Lim J, Kim MY, Kim SG, Suk KT, Jang JY, An H, Yim HJ, Seo YS
- KMID: 2540418
- Gut Liver.
- 2023 Mar;17(2):299-307.
- doi: 10.5009/gnl220032
Background/Aims: We investigated the factors related to spleen length and the diagnostic accuracy of a model using spleen length corrected by related factors, for the prediction of varices needing treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
-
Han E, Lee Yh, Lee JS, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, Lee BW, Kang ES, Cha BS, Kim SU
- KMID: 2533187
- Gut Liver.
- 2022 Sep;16(5):786-797.
- doi: 10.5009/gnl210290
Background/Aims: Metabolic dysfunction associated fatty liver disease (MAFLD) has recently been introduced to compensate for the conventional concept of nonalcoholic fatty liver disease (NAFLD). We explored whether fibrotic burden determines... -
- CITED
-
- Close
- SHARE
-
- Close
- Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
-
Kim Y, Han E, Lee JS, Lee HW, Kim BK, Kim MK, Kim HS, Park JY, Kim DY, Ahn SH, Lee BW, Kang ES, Cha BS, Lee Yh, Kim SU
- KMID: 2527001
- Gut Liver.
- 2022 Mar;16(2):290-299.
- doi: 10.5009/gnl210084
Background/Aims: Nonalcoholic fatty liver disease (NAFLD) and obesity are independently associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD), the leading cause of mortality in patients with NAFLD. Many... -
- CITED
-
- Close
- SHARE
-
- Close
- Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma
-
Lee SW, Choi J, Kim SU, Lim YS
- KMID: 2517623
- Clin Mol Hepatol.
- 2021 Jul;27(3):402-412.
- doi: 10.3350/cmh.2021.0179
Over the past several decades, entecavir (ETV) and tenofovir disoproxil fumarate (TDF) have remained the first-line antiviral agents in several international guidelines. These two antiviral agents have shown similar short... -
- CITED
-
- Close
- SHARE
-
- Close
- KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
-
Kang SH, Lee HW, Yoo JJ, Cho Y, Kim SU, Lee TH, Jang BK, Kim SG, Ahn SB, Kim H, Jun DW, Choi JI, Song DS, Kim W, Jeong SW, Kim MY, Koh H, Jeong S, Lee JW, Cho YK, The Korean Association for the Study of the Liver (KASL)
- KMID: 2517622
- Clin Mol Hepatol.
- 2021 Jul;27(3):363-401.
- doi: 10.3350/cmh.2021.0178
-
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Human or Mouse IL-7 on the Homeostasis of Porcine T Lymphocytes
-
Hong JH, Kim SH, Kim HG, Jang JH, Son RG, Pack SP, Park YH, Kang P, Jeong KJ, Kim JS, Choi H, Kim SU, Jung YW
- KMID: 2518349
- Immune Netw.
- 2021 Jun;21(3):e24.
- doi: 10.4110/in.2021.21.e24
Due to the inconsistent fluctuation of blood supply for transfusion, much attention has been paid to the development of artificial blood using other animals. Although mini-pigs are candidate animals, contamination... -
- CITED
-
- Close
- SHARE
-
- Close
- Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma
-
Lee HA, Lee YS, Kim BK, Jung YK, Kim SU, Park JY, Kim JH, An H, Kim DY, Yim HJ, Ahn SH, Yeon JE, Byun KS, Han KH, Um SH, Seo YS
- KMID: 2515846
- Gut Liver.
- 2021 May;15(3):420-429.
- doi: 10.5009/gnl20101
Background/Aims: We investigated changes in recurrence rates and significant recurrence predictors over time after complete cure of hepatocellular carcinoma (HCC). Methods: A total of 1,491 patients with first-time diagnosis of Barcelona... -
- CITED
-
- Close
- SHARE
-
- Close
- Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
-
Kim DS, Park SY, Kim BK, Park JY, Kim DY, Han KH, Lee YR, Tak WY, Kweon YO, Jung I, Han M, Kim EH, Ahn SH, Kim SU
- KMID: 2515086
- J Korean Med Sci.
- 2021 Apr;36(16):e105.
- doi: 10.3346/jkms.2021.36.e105
Background: Since September 2015, the initiation of antiviral therapy (AVT) for patients with chronic hepatitis B (CHB)-related cirrhosis has been reimbursed according to the revised Korean Association for the Study... -
- CITED
-
- Close
- SHARE
-
- Close
- From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
-
Kang SH, Cho Y, Jeong SW, Kim SU, Lee JW, On behalf of Korean NAFLD Study Group
- KMID: 2514765
- Clin Mol Hepatol.
- 2021 Apr;27(2):257-269.
- doi: 10.3350/cmh.2021.0067
There is some dissatisfaction with the term “nonalcoholic fatty liver disease (NAFLD),” which overemphasizes alcohol and underemphasizes the importance of metabolic risk factors in this disease. Recently, a consensus recommended... -
- CITED
-
- Close
- SHARE
-
- Close
- Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
-
Jeon MY, Kim BK, Lee JS, Lee HW, Park JY, Kim DY, Ahn SH, Han KH, Kim SU
- KMID: 2514771
- Clin Mol Hepatol.
- 2021 Apr;27(2):295-304.
- doi: 10.3350/cmh.2020.0216
Background/Aims: The immune-tolerant (IT) phase of chronic hepatitis B (CHB) patients is not generally indicative of antiviral therapy (AVT). We assessed and compared the risk of hepatocellular carcinoma (HCC) during... -
- CITED
-
- Close
- SHARE
-
- Close
- Advanced Stage Hepatocellular Carcinoma Successfully Treated with Liver-directed Concurrent Chemoradiotherapy and Sequential Transarterial Radio-embolization
-
Noh M, Kim BK, Kim SU
- KMID: 2514241
- J Liver Cancer.
- 2021 Mar;21(1):97-103.
- doi: 10.17998/jlc.21.1.97
Optimal treatment strategies for patients with advanced hepatocellular carcinoma (HCC) is yet to be determined. Herein, we present a case of advanced HCC with tumor invasion into the right anterior... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer
-
Song JW, Chun HS, Lee JS, Lee HW, Kim BK, Kim SU, Park JY, Ahn SH, Park YN, Han DH, Kim DY
- KMID: 2514236
- J Liver Cancer.
- 2021 Mar;21(1):69-75.
- doi: 10.17998/jlc.21.1.69
Hepatocellular carcinoma (HCC) primarily originates in the liver with hepatic differentiation. However, HCCs are not homogenous, and approximately 35% of HCC cases are classified as histopathological variants that present distinct... -
- CITED
-
- Close
- SHARE
-
- Close
- Epidemiological Study of Malignant Gliomas in Korea Using Nationwide Dataset from 2007 to 2017
-
Kim SU, Ahn S, Lee JE, Han KD, Park SH, Yang SH
- KMID: 2513588
- J Korean Med Sci.
- 2021 Mar;36(9):e68.
- doi: 10.3346/jkms.2021.36.e68
Background: The purpose of the study was to investigate the incidence, prevalence, and survival of malignant gliomas (MGs) using population-based Korean National Health Insurance Database (NHID) data. Methods: Using the Korean... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
-
Lee JS, Chon YE, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kang W, Choi MS, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Kim HY, Kim TH, Yoo K, Ha Y, Kim MN, Lee JH, Hwang SG, Kim SS, Cho HJ, Cheong JY, Cho SW, Park SH, Heo NY, Hong YM, Yoon KT, Cho M, Park JG, Kang MK, Park SY, Kweon YO, Tak WY, Jang SY, Sinn DH, Kim SU, The Korean TACE Study Group
- KMID: 2509849
- Yonsei Med J.
- 2021 Jan;62(1):12-20.
- doi: 10.3349/ymj.2021.62.1.12
Purpose: Alpha-fetoprotein (AFP) is a prognostic marker for hepatocellular carcinoma (HCC). We investigated the prognostic value of AFP levels in patients who achieved complete response (CR) to transarterial chemoembolization (TACE)... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
-
Chang JW, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim SU
- KMID: 2513683
- Gut Liver.
- 2021 Jan;15(1):117-127.
- doi: 10.5009/gnl19301
Background/Aims: The hepatic steatosis index (HSI) is a noninvasive method to assess the severity of hepatic steatosis. Antiviral therapy (AVT) can impact aspartate aminotransferase and alanine aminotransferase levels, which are... -
- CITED
-
- Close
- SHARE
-
- Close
- The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization
-
Lee JS, Choi HJ, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Baek SE, Chung YE, Park MS, Kim MJ, Rhee Hj, Kim SU
- KMID: 2508695
- Gut Liver.
- 2020 Nov;14(6):765-774.
- doi: 10.5009/gnl19197
Background/Aims: The Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 and modified RECIST (mRECIST) criteria have been used to assess treatment responses for hepatocellular carcinoma (HCC) patients. We investigated which... -
- CITED
-
- Close
- SHARE
-
- Close
- Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study
-
Yoo JJ, Yoo YJ, Moon WR, Kim SU, Jeong SW, Park HN, Park MG, Jang JY, Park SY, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim SG, Kim YS, Kim JH, Yeon JE, Byun KS
- KMID: 2508131
- Korean J Intern Med.
- 2020 Nov;35(6):1346-1353.
- doi: 10.3904/kjim.2018.309
Background/Aims: The controlled attenuation parameter (CAP), based on transient elastography, is widely used for noninvasive assessment of the degree of hepatic steatosis (HS). We investigated the correlation of the degree... -
- CITED
-
- Close
- SHARE
-
- Close
- Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus
-
Sung MJ, Lim TS, Jeon MY, Lee HW, Kim BK, Kim DY, Ahn SH, Han KH, Park JY, Kim SU
- KMID: 2506437
- Gut Liver.
- 2020 Sep;14(5):626-635.
- doi: 10.5009/gnl19126
Background/Aims: Sarcopenia is associated with liver fi- brosis in patients with nonalcoholic fatty liver disease and chronic hepatitis B. We investigated the association between sarcopenia and hepatic fibrotic burden in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study
-
Jeon MY, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Lee JH, Yu SJ, Kim YJ, Yoon JH, Cho EJ, Kim SU
- KMID: 2504204
- Gut Liver.
- 2020 Jul;14(4):477-485.
- doi: 10.5009/gnl19111
Background/Aims: Prognostic models are lacking for patients with recurrent hepatocellular carcinoma (HCC) following surgical resection. This study devised and validated a new hepatoma arterial-embolization prognostic (HAP) score optimized for use... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B
-
Jung YW, Kim M, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim SU
- KMID: 2500207
- J Korean Med Sci.
- 2020 Apr;35(17):e104.
- doi: 10.3346/jkms.2020.35.e104
Background: Besifovir dipivoxil maleate (BSV) with L-carnitine is the first-line antiviral agent for chronic hepatitis B (CHB) infection. We investigated whether BSV combined with L-carnitine improves hepatic steatosis (HS). Methods: Treatment-naïve... -
- CITED
-
- Close
- SHARE
-
- Close
